Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C

Elderly Patients ◽

Mitomycin C ◽

Subgroup Analysis ◽

Controlled Trial ◽

Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial

The Lancet ◽

10.1016/s0140-6736(07)61086-1 ◽

2007 ◽

Vol 370 (9582) ◽

pp. 135-142 ◽

Cited By ~ 444

Author(s):

Miriam Koopman ◽

Ninja F Antonini ◽

Joep Douma ◽

Jaap Wals ◽

Aafke H Honkoop ◽

...

Keyword(s):

Colorectal Cancer ◽

Controlled Trial ◽

Phase Iii ◽

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial

The Lancet ◽

10.1016/s0140-6736(07)61087-3 ◽

2007 ◽

Vol 370 (9582) ◽

pp. 143-152 ◽

Cited By ~ 391

Author(s):

Matthew T Seymour ◽

Timothy S Maughan ◽

Jonathan A Ledermann ◽

Clare Topham ◽

Roger James ◽

...

Keyword(s):

Colorectal Cancer ◽

Poor Prognosis ◽

Controlled Trial ◽

Randomised Controlled ◽

Patients With Poor Prognosis

Different strategies of sequential and combination chemotherapy for patients with poor prognosis advanced colorectal cancer (MRC FOCUS): a randomised controlled trial

Yearbook of Oncology ◽

10.1016/s1040-1741(08)79030-4 ◽

2008 ◽

Vol 2008 ◽

pp. 239-242

Author(s):

P.J. Loehrer

Keyword(s):

Colorectal Cancer ◽

Poor Prognosis ◽

Controlled Trial ◽

Randomised Controlled ◽

Patients With Poor Prognosis

Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial

Yearbook of Oncology ◽

10.1016/s1040-1741(08)79022-5 ◽

2008 ◽

Vol 2008 ◽

pp. 234-236

Author(s):

P.J. Loehrer

Keyword(s):

Colorectal Cancer ◽

Controlled Trial ◽

Phase Iii ◽

Faculty Opinions recommendation of Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1116051.573867 ◽

2008 ◽

Author(s):

Martine Extermann

Keyword(s):

Elderly Patients ◽

B Cell ◽

Controlled Trial ◽

B Cell Lymphomas ◽

Faculty Opinions recommendation of Stroke treatment with alteplase given 3.0-4.5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1168144.630276 ◽

2009 ◽

Author(s):

David Liebeskind

Keyword(s):

Ischaemic Stroke ◽

Acute Ischaemic Stroke ◽

Subgroup Analysis ◽

Controlled Trial ◽

Stroke Treatment ◽

Faculty Opinions recommendation of Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.3801959.6624054 ◽

2010 ◽

Author(s):

Atul Kumar ◽

Bhawna Halwan

Keyword(s):

Colorectal Cancer ◽

Flexible Sigmoidoscopy ◽

Controlled Trial ◽

Faculty Opinions recommendation of Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717964810.793469147 ◽

2013 ◽

Author(s):

Yiqian Nancy You ◽

Brian Keith Bednarski

Keyword(s):

Colorectal Cancer ◽

Cancer Risk ◽

Resistant Starch ◽

Controlled Trial ◽

Hereditary Colorectal Cancer ◽

Term Effect ◽

Long Term Effect ◽

Upfront FOLFOXIRI Plus Bevacizumab and Reintroduction after Progression versus mFOLFOX6 Plus Bevacizumab Followed by FOLFIRI Plus Bevacizumab in the Treatment of Patients with Metastatic Colorectal Cancer (TRIBE2): A Multicentre, Open-Label, Phase 3, Randomised Controlled Trial by GONO

SSRN Electronic Journal ◽

10.2139/ssrn.3478102 ◽

2019 ◽

Author(s):

Chiara Cremolini ◽

Carlotta Antoniotti ◽

Daniele Rossini ◽

Sara Lonardi ◽

Fotios Loupakis ◽

...

Keyword(s):

Colorectal Cancer ◽

Metastatic Colorectal Cancer ◽

Controlled Trial ◽

Open Label ◽

Phase 3 ◽

Open Label Phase ◽

Impact and acceptability of HIV self-testing for trans men and trans women: A mixed-methods subgroup analysis of the SELPHI randomised controlled trial and process evaluation in England and Wales

EClinicalMedicine ◽

10.1016/j.eclinm.2020.100700 ◽

2021 ◽

Vol 32 ◽

pp. 100700

Author(s):

T. Charles Witzel ◽

Talen Wright ◽

Leanne McCabe ◽

Michelle M. Gabriel ◽

Aedan Wolton ◽

...

Keyword(s):

Mixed Methods ◽

Process Evaluation ◽

Subgroup Analysis ◽

Controlled Trial ◽

England And Wales ◽

Trans Men ◽

Self Testing ◽

Trans Women ◽